You may have heard about the BTA stat test and its effectiveness for detecting recurrent bladder cancer.

Below are some common questions and answers to help you better understand this test and how you or your family member can benefit from it.

HOW COMMON IS BLADDER CANCER?

Bladder cancer is the fourth most common cancer among men. Approximately 79,000 new cases are diagnosed in the US each year. This adds to the 800,000 bladder cancer patients who require lifelong monitoring.

WHY IS IT IMPORTANT FOR BLADDER CANCER PATIENTS TO BE MONITORED FOR A LIFETIME?

Approximately 8 out of 10 newly diagnosed bladder cancer patients show recurrence - that is the cancer returns - within the first year. Early detection greatly increases the chance of survival. The 5-year survival rate is 79% in white men, 74% in white women, 69% in black men and 54% in black women* if the cancer is caught early and 10% if it is detected late. 

WHY IS THE BTA STAT TEST IMPORTANT?

The test may provide doctors with information that could lead to early detection of recurrent bladder cancer, therefore, providing for earlier treatment and increased survival rate.

WHAT IS THE BTA STAT TEST?

The BTA stat test is a simple one-step test that measures a substance produced by bladder tumors. The test is simple, uses only 3 drops of urine, and takes 5 minutes.

IS THERE ANY DISCOMFORT OR SPECIAL PROCEDURES?

No! The test requires one urine sample. The sample is collected in a plastic cup provided by the doctor.

HOW IS THE TEST DONE?

A urines sample is collected in a plastic cup. The test is performed by the doctor or his staff using 3 drops of urine and then waiting 5 minutes for the result. The test may also be done by the patient at home.
 

* American Cancer Society Cancer Facts & Figures 2017

FAQ's